Hims & Hers Surges on Novo Obesity Deal That Ends Public Feud

Hims & Hers Health Inc. surged after Novo Nordisk A/S was said to have ended its public feud with the company with an agreement to sell its weight-loss drugs on...

By Naomi Kresge, Madison Muller · Bloomberg

Hims & Hers Health Inc. surged after Novo Nordisk A/S was said to have ended its public feud with the company with an agreement to sell its weight-loss drugs on the Hims platform.